LAEKNA INC
(HKEX: 2105)
Laekna, Inc. engages in the provision of clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
13.620 -
-0.160
(-1.16%)
Range
13.520 - 14.220
(5.18%)
Open
13.990
Previous Close
13.780
Bid Price
13.610
Bid Volume
('000)
2
Ask Price
13.620
Ask Volume
('000)
2
Volume
('000)
1,822
Value
25,072,259
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
